The role of Dual Blockade in management of HER2+ Breast cancer
Starting on:
Mar 22, 2024
Ending on:
Mar 22, 2024
Moderator(s):
Dr. Njoki Njiraini
Consultant RADIOTHERAPY & ONCOLOGY
Venue:
Hyatt Regency, Nairobi
Max Credits:
3 Points

Provider:
Heart and Life Conferences
Claim Points

The role of Dual Blockade in management of HER2+ Breast cancer

Starting on:
Mar 22, 2024
Ending on:
Mar 22, 2024
Venue:
Hyatt Regency, Nairobi

Description

Roche invites you to the Launch of PHESGO - Revolutionizing Breast Cancer Treatment

Objectives

-Revolutionizing Breast Cancer Treatment -The role of Dual Blockade in management of HER2+ Breast cancer -Flexible care ( Keynote) -Redefining Anti- HER 2 Breast Cancer Care - Tell Her story

Presenters

  1. Dr. Angela Kiraba


  2. Dr. Kasmani Riaz


  3. Dr. Sitna Mwanz


  4. Dr. Elias Melly


Search For CPD Activity